Option Care Health, Inc. (OPCH) Stock
OPCH has an Alpha Score of 48 out of 100 (weak), computed on Nov 1, 2026 from 3 of 4 sub-scores. 1 member of Congress disclosed 4 trades in OPCH since 2025: 2 purchases and 2 sales, most recently Lisa McClain (sale, Oct 31, 2025). 5 of the hedge funds AlphaScala tracks reported OPCH in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Millennium Management's at $54.92M. Its trailing P/E ratio is 22.8 and its net margin 3.7% (key statistics as of Nov 1, 2026).
What is OPCH's Alpha Score?
How it works →Alpha Score of 48 reflects weak overall profile with moderate momentum, weak value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 1, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded Option Care Health, Inc. (OPCH)?
Most recent: Lisa McClain (sale, Oct 31, 2025); records start Sep 25, 2025.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Lisa McClain R-MI · House | 2025-10-31 | sale | $1k – $15k |
| Lisa McClain R-MI · House | 2025-10-30 | purchase | $1k – $15k |
| Lisa McClain R-MI · House | 2025-10-30 | sale | $1k – $15k |
| Lisa McClain R-MI · House | 2025-09-25 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026.
See all OPCH political trades →Which hedge funds own OPCH?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Millennium Management Israel Englander | 2.62M | $54.92M | +60% |
| Point72 Steve Cohen | 1.80M | $37.75M | +220% |
| Citadel Ken Griffin | 1.63M | $34.26M | -54% |
| D.E. Shaw David Shaw | 284K | $5.96M | +89% |
| Bridgewater Associates Ray Dalio | 110K | $2.31M | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →What are OPCH's key statistics?
Key statistics as of Nov 1, 2026
How does OPCH's valuation compare with the Healthcare sector?
| Metric | OPCH | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 22.8 | 28.8 | 111 |
| Net margin | 3.68% | 3.66% | 168 |
| Return on equity | 15.83% | 3.80% | 191 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 8, 2026). P/E excludes loss-making companies.
OPCH price chart
Powered by TradingViewWhat does Option Care Health, Inc. do?
Option Care Health Inc. operates as a healthcare services company, primarily engaged in providing infusion therapy and other related services. Its core function revolves around delivering comprehensive care through its network of facilities, home-based services, and care management programs. Option Care Health Inc. specializes in treatments for critical illnesses such as immune disorders, cancer, and chronic conditions, offering personalized care plans tailored to individual patient needs. This company is instrumental in the health services sector, bridging the gap between hospitals and home-based care, which is crucial for patient recovery and ongoing treatment. With a strong emphasis on clinical expertise and patient-focused care, Option Care Health Inc. stands out in the healthcare market, addressing the growing demand for specialty medications and the need for integrated healthcare solutions. Its services are essential for enhancing patient outcomes and managing complex health conditions outside traditional hospital settings.